Drugs / Chidemide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05931263 | Jun 2023 → Feb 2026 overdue | peripheral T-cell lymphoma, not otherwise specified | The First Affiliated Hospital with Nanjing Medical University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chidemide | “Chidemide，carmustine, etoposide, cytarabine, and melphalan” NCT05931263 ↗ |